SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Eric Linsley to join panel at the MedTech Investing Conference in Minneapolis, MN
News | 05. 10. 2006
